Antoinette Perry
Antoinette Perry
Verified email at - Homepage
Cited by
Cited by
Localized hypermutation and associated gene losses in legume chloroplast genomes
AM Magee, S Aspinall, DW Rice, BP Cusack, M Sémon, AS Perry, ...
Genome research 20 (12), 1700-1710, 2010
The epigenome as a therapeutic target in prostate cancer
AS Perry, RWG Watson, M Lawler, D Hollywood
Nature Reviews Urology 7 (12), 668-680, 2010
Nucleotide substitution rates in legume chloroplast DNA depend on the presence of the inverted repeat
AS Perry, KH Wolfe
Journal of Molecular Evolution 55 (5), 501-508, 2002
The emerging roles of DNA methylation in the clinical management of prostate cancer
AS Perry, R Foley, K Woodson, M Lawler
Endocrine-related cancer 13 (2), 357-377, 2006
Long noncoding RNAs and prostate carcinogenesis: the missing ‘linc’?
AL Walsh, AV Tuzova, EM Bolton, TH Lynch, AS Perry
Trends in molecular medicine 20 (8), 428-436, 2014
Epigenetics of malignant melanoma
B Moran, R Silva, AS Perry, WM Gallagher
Seminars in cancer biology 51, 80-88, 2018
The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer
TM Murphy, AS Perry, M Lawler
Endocrine-Related Cancer 15 (1), 11, 2008
Noncoding RNAs in prostate cancer: the long and the short of it
EM Bolton, AV Tuzova, AL Walsh, T Lynch, AS Perry
Clinical Cancer Research 20 (1), 35-43, 2014
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer
AS Perry, G O'Hurley, OA Raheem, K Brennan, S Wong, A O'Grady, ...
International journal of cancer 132 (8), 1771-1780, 2013
The HIF-1α C1772T polymorphism may be associated with susceptibility to clinically localized prostate cancer but not with elevated expression of hypoxic biomarkers
R Foley, L Marignol, AZ Thomas, IM Cullen, AS Perry, P Tewari, ...
Cancer biology & therapy 8 (2), 118-124, 2009
In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer
AS Perry, B Loftus, R Moroose, TH Lynch, D Hollywood, RWG Watson, ...
British journal of cancer 96 (10), 1587-1594, 2007
The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date
SM Bruinsma, L Zhang, MJ Roobol, CH Bangma, EW Steyerberg, ...
Wiley 121 (5), 737-744, 2018
Reasons for discontinuing active surveillance: assessment of 21 centres in 12 countries in the Movember GAP3 Consortium
M Van Hemelrijck, X Ji, J Helleman, MJ Roobol, W van der Linden, ...
European urology 75 (3), 523-531, 2019
No evidence of XMRV in Irish prostate cancer patients with the R462Q mutation
F D'arcy, R Foley, A Perry, L Marignol, M Lawler, E Gaffney, RGW Watson, ...
European Urology Supplements 3 (7), 271, 2008
MicroRNAs as putative mediators of treatment response in prostate cancer
F O'kelly, L Marignol, A Meunier, TH Lynch, AS Perry, D Hollywood
Nature Reviews Urology 9 (7), 397-407, 2012
Evolutionary re-organisation of a large operon in adzuki bean chloroplast DNA caused by inverted repeat movement
AS Perry, S Brennan, DJ Murphy, TA Kavanagh, KH Wolfe
DNA research 9 (5), 157-162, 2002
Improving multivariable prostate cancer risk assessment using the Prostate Health Index
RW Foley, L Gorman, N Sharifi, K Murphy, H Moore, AV Tuzova, AS Perry, ...
BJU international 117 (3), 409-417, 2016
Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor
SG Gray, AM Baird, F O'Kelly, G Nikolaidis, M Almgren, A Meunier, ...
International journal of molecular medicine 30 (6), 1505-1511, 2012
IGFBP7 Promoter Methylation and Gene Expression Analysis in Prostate Cancer
L Sullivan, TM Murphy, C Barrett, B Loftus, J Thornhill, M Lawler, ...
The Journal of urology 188 (4), 1354-1360, 2012
epiCaPture: a urine DNA methylation test for early detection of aggressive prostate cancer
E O’Reilly, AV Tuzova, AL Walsh, NM Russell, O O’Brien, S Kelly, ...
JCO precision oncology 3, 1-18, 2019
The system can't perform the operation now. Try again later.
Articles 1–20